All In MedTech

FDA Clearance Tracker · P170003-S024

Lutonix Drug Coated Balloon PTA Catheter

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 16, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 16, 2021

Approved

Time to decision

83 days

Received Sep 24, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P170003-S024
Device name
Lutonix Drug Coated Balloon PTA Catheter
Applicant
Lutonix
Applicant location
New Hope, MN
Received
Sep 24, 2021
Decided
Dec 16, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P170003

Device type

Device class
Class III

Every decision under product code PRC

FDA's approval statement

As written in FDA's record.

Approval of the revised protocol for the New Enrollment Post Approval Study Registry.

Source documents

Other decisions for Lutonix

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.